References

GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2018 · External reference

Sexual dimorphism in the incidence of human cancers

10.1186/s12885-019-5902-z · 2019 · External reference

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries, The Lancet

2018 · External reference

10.1016/j.ejca.2017.07.013

10.1016/j.ejca.2017.07.013 · External reference

Sex differences in cancer survival in Estonia: a population-based study

10.1186/s12885-015-1080-9 · 2015 · External reference

Sex Disparities in the Clinical Characteristics, Synchronous Distant Metastasis Occurrence and Prognosis: A Pan-cancer Analysis

10.7150/jca.50536 · 2021 · External reference

Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)

10.1016/j.ejca.2020.06.005 · 2020 · External reference

Gender Differences in Gastric Cancer Survival: 99,922 Cases Based on the SEER Database

10.1007/s11605-019-04304-y · 2020 · External reference

Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer

10.1245/s10434-016-5448-0 · 2016 · External reference

Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts

10.3390/cancers12082082 · 2020 · External reference

10.1016/j.tox.2020.152546

10.1016/j.tox.2020.152546 · External reference

10.1002/ijc.32327

10.1002/ijc.32327 · External reference

10.1038/nrc.2016.30

10.1038/nrc.2016.30 · External reference

10.1016/j.tig.2020.06.016

10.1016/j.tig.2020.06.016 · External reference

10.1158/1078-0432.ccr-20-1741

10.1158/1078-0432.ccr-20-1741 · External reference

10.1038/ng.3726

10.1038/ng.3726 · External reference

Sex differences in oncogenic mutational processes

10.1038/s41467-020-17359-2 · 2020 · External reference

10.1016/s1470-2045(18)30261-4

10.1016/s1470-2045(18)30261-4 · External reference

Sex and Gender Influences on Cancer Immunotherapy Response

10.3390/biomedicines8070232 · 2020 · External reference

Strength of immune selection in tumors varies with sex and age

10.1038/s41467-020-17981-0 · 2020 · External reference

10.1016/j.cell.2018.02.052

10.1016/j.cell.2018.02.052 · External reference

10.1016/j.ccell.2021.04.014

10.1016/j.ccell.2021.04.014 · External reference

10.1038/ncomms3612

10.1038/ncomms3612 · External reference

10.1186/s13059-014-0550-8

10.1186/s13059-014-0550-8 · External reference

10.7554/elife.05005

10.7554/elife.05005 · External reference

10.1093/bioinformatics/btt684

10.1093/bioinformatics/btt684 · External reference

CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications

10.7554/elife.50267 · 2020 · External reference

10.1101/2020.12.14.422647

10.1101/2020.12.14.422647 · External reference

10.1038/nmeth.3337

10.1038/nmeth.3337 · External reference

10.1186/s13073-019-0638-6

10.1186/s13073-019-0638-6 · External reference

10.1093/nar/gkaa407

10.1093/nar/gkaa407 · External reference

10.1016/j.celrep.2016.12.019

10.1016/j.celrep.2016.12.019 · External reference

10.1186/s13059-016-1070-5

10.1186/s13059-016-1070-5 · External reference

10.7554/elife.26476

10.7554/elife.26476 · External reference

10.1016/j.cell.2018.03.022

10.1016/j.cell.2018.03.022 · External reference

10.1186/s13073-020-0721-z

10.1186/s13073-020-0721-z · External reference

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

10.7554/elife.37294 · 2018 · External reference

10.1093/annonc/mdy495

10.1093/annonc/mdy495 · External reference

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

2016 · External reference